This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Medical Practice  • Medical Practice, Other  • Dermatologic Disorders  • Alopecia  • Hair Disorders  • Neoplasms  • Women's Health  • Women's Health, Other  • Dermatologic Disorders, Other  • Dermatology, Other  • Drug Therapy  • Drug Therapy, Other  • Humanities  • Medicine and the Media  • Alert me on articles by topic  Social Bookmarking   What's this?

Jeremy S. Tilstra, BS; Noel Prevost, PA-C; Pooja Khera, MD; Joseph C. English III, MD

Arch Dermatol. 2009;145(9):1062-1063.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

A novel study by Kasteler and Callen¹ published in 1994 defined scalp involvement as a common and symptomatic (ie, pruritic) manifestation of dermatomyositis (DM). They defined this involvement as "diffuse, scaly dermatosis with erythema (Figure), atrophy, and often nonscarring alopecia"^1(p1940) present in 82% of their patients with DM. Because therapy to control the often debilitating scalp symptoms of DM is lacking, we conducted a retrospective study to compare the DM cases reported by Kasteler and Callen¹ with our own current population to determine similarities and difference and to evaluate whether any of the systemic therapeutic ladders used to treat DM^2-3 were optimal for treating symptomatic scalp DM.

Figure appears in full text version. Figure. Scaling diffuse erythema of the scalp consistent with scalp dermatomyositis.

Methods

After approval from the institutional review board, we evaluated our patients' medical charts from 2003 . . . [Full Text of this Article]

Results

Comment

AUTHOR INFORMATION


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?